Cargando…

Short-term Mortality Outcomes of HIV-Associated Cryptococcal Meningitis in Antiretroviral Therapy–Naïve and –Experienced Patients in Sub-Saharan Africa

BACKGROUND: An increasing proportion of patients with HIV-associated cryptococcal meningitis have received antiretroviral therapy (ART) before presentation. There is some evidence suggesting an increased 2-week mortality in those receiving ART for <14 days compared with those on ART for >14 da...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalata, Newton, Ellis, Jayne, Kanyama, Cecilia, Kuoanfank, Charles, Temfack, Elvis, Mfinanga, Sayoki, Lesikari, Sokoine, Chanda, Duncan, Lakhi, Shabir, Nyazika, Tinashe, Chan, Adrienne K, van Oosterhout, Joep J, Chen, Tao, Hosseinipour, Mina C, Lortholary, Olivier, Wang, Duolao, Jaffar, Shabbar, Loyse, Angela, Heyderman, Robert S, Harrison, Thomas S, Molloy, Síle F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501291/ https://www.ncbi.nlm.nih.gov/pubmed/34646905 http://dx.doi.org/10.1093/ofid/ofab397

Ejemplares similares

Fungal Burden and Raised Intracranial Pressure Are Independently Associated With Visual Loss in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis
por: Molloy, Síle F, et al.
Publicado: (2021)

Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa
por: Chen, Tao, et al.
Publicado: (2019)

Addition of Flucytosine to Fluconazole for the Treatment of Cryptococcal Meningitis in Africa: A Multicountry Cost-effectiveness Analysis
por: Shiri, Tinevimbo, et al.
Publicado: (2020)

P449 Semi-quantitative cryptococcal antigen rapid test (CryptoPS, Biosynex®) for cryptococcal meningitis in patients living with HIV in Sub-Saharan Africa: prospective multicenter diagnostic accuracy study (DREAMM)
por: Leclere, Research Engineer Aude Sturny, et al.
Publicado: (2022)

One-year Mortality Outcomes From the Advancing Cryptococcal Meningitis Treatment for Africa Trial of Cryptococcal Meningitis Treatment in Malawi
por: Kanyama, Cecilia, et al.
Publicado: (2020)

Cryptococcal meningitis: A neglected NTD?
por: Molloy, Síle F., et al.
Publicado: (2017)

S7.1d Reliability of bedside point-of-care tests for Candida neoformans , M. tuberculosis and S. pneumoniae in adults living with HIV presenting with suspected central nervous system infection (CNS) in low- and middle-income settings: Preliminary results from the DREAMM study
por: Leclere, Aude Sturny, et al.
Publicado: (2022)

Effect of oral fluconazole 1200 mg/day on QT interval in African adults with HIV-associated cryptococcal meningitis
por: Molloy, Síle F., et al.
Publicado: (2018)

Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test
por: Temfack, Elvis, et al.
Publicado: (2018)

Cryptococcal Meningitis Screening and Community-based Early Adherence Support in People With Advanced Human Immunodeficiency Virus Infection Starting Antiretroviral Therapy in Tanzania and Zambia: A Cost-effectiveness Analysis
por: Kimaro, Godfather Dickson, et al.
Publicado: (2020)

Dynamic ploidy changes drive fluconazole resistance in human cryptococcal meningitis
por: Stone, Neil R.H., et al.
Publicado: (2019)

Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
por: Jarvis, Joseph N, et al.
Publicado: (2022)

AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
por: Lawrence, David S., et al.
Publicado: (2018)

Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial
por: Lawrence, David S., et al.
Publicado: (2019)

The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies
por: Kimaro, Godfather Dickson, et al.
Publicado: (2017)

The acceptability of integrated healthcare services for HIV and non-communicable diseases: experiences from patients and healthcare workers in Tanzania
por: Shayo, Elizabeth H., et al.
Publicado: (2022)

Scaling up integrated care for HIV and other chronic conditions in routine health care settings in sub-Saharan Africa: Field notes from Uganda
por: Moyo, Faith, et al.
Publicado: (2023)

Metformin for the prevention of diabetes among people with HIV and either impaired fasting glucose or impaired glucose tolerance (prediabetes) in Tanzania: a Phase II randomised placebo-controlled trial
por: Garrib, Anupam, et al.
Publicado: (2023)

Implementation of WHO guidelines on management of advanced HIV disease and its impact among TB co-infected patients in Tanzania: a retrospective follow-up study
por: Hassan, Frank E., et al.
Publicado: (2022)

Recent advances in managing HIV-associated cryptococcal meningitis
por: Boyer-Chammard, Timothée, et al.
Publicado: (2019)

Fungal CNS Infections in Africa: The Neuroimmunology of Cryptococcal Meningitis
por: Mohamed, Sally H., et al.
Publicado: (2022)

AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study
por: Ponatshego, Ponego Lloyd, et al.
Publicado: (2019)

Management of chronic conditions in resource limited settings: multi stakeholders’ perception and experiences with receiving and providing integrated HIV, diabetes and hypertension services in Tanzania
por: Shayo, Elizabeth H., et al.
Publicado: (2023)

Pneumococcal pneumonia and carriage in Africa before and after introduction of pneumococcal conjugate vaccines, 2000–2019: protocol for systematic review
por: Kalata, Newton L., et al.
Publicado: (2019)

Epidemiology and aetiologies of cryptococcal meningitis in Africa, 1950–2017: protocol for a systematic review
por: Nyazika, Tinashe K, et al.
Publicado: (2018)

Combination Therapy for HIV-Associated Cryptococcal Meningitis—A Success Story
por: Hurt, William J., et al.
Publicado: (2021)

Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes
por: Jarvis, Joseph N., et al.
Publicado: (2014)

Ischemic stroke as a complication of cryptococcal meningitis and immune reconstitution inflammatory syndrome: a case report
por: Ellis, Jayne P., et al.
Publicado: (2018)

Neurological deterioration in a patient with HIV-associated cryptococcal meningitis initially improving on antifungal treatment: a case report of coincidental racemose neurocysticercosis
por: Kalata, Newton, et al.
Publicado: (2021)

Genomic Variation across a Clinical Cryptococcus Population Linked to Disease Outcome
por: Sephton-Clark, Poppy, et al.
Publicado: (2022)

Cryptococcal Antigenemia in Advanced Human Immunodeficiency Virus Disease: Pathophysiology, Epidemiology, and Clinical Implications
por: Wake, Rachel M, et al.
Publicado: (2022)

Patient and health provider costs of integrated HIV, diabetes and hypertension ambulatory health services in low-income settings — an empirical socio-economic cohort study in Tanzania and Uganda
por: Shiri, Tinevimbo, et al.
Publicado: (2021)

Implementation of tuberculosis and cryptococcal meningitis rapid diagnostic tests amongst patients with advanced HIV at Kamuzu Central Hospital, Malawi, 2016–2017
por: Kanyama, Cecilia, et al.
Publicado: (2022)

A Prospective Longitudinal Study of the Clinical Outcomes from Cryptococcal Meningitis following Treatment Induction with 800 mg Oral Fluconazole in Blantyre, Malawi
por: Rothe, Camilla, et al.
Publicado: (2013)

Integration of non-communicable disease and HIV/AIDS management: a review of healthcare policies and plans in East Africa
por: Adeyemi, Olukemi, et al.
Publicado: (2021)

Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: A systematic review and meta-analysis
por: Aikaeli, Faith, et al.
Publicado: (2022)

Integrating health services for HIV infection, diabetes and hypertension in sub-Saharan Africa: a cohort study
por: Birungi, Josephine, et al.
Publicado: (2021)

Diagnostic Accuracy of the Biosynex CryptoPS Cryptococcal Antigen Semiquantitative Lateral Flow Assay in Patients with Advanced HIV Disease
por: Tenforde, Mark W., et al.
Publicado: (2020)

The treatment of a pregnant HIV positive patient with cryptococcal meningitis in Malawi. Case report and review of treatment options
por: Bright, Philip D., et al.
Publicado: (2017)

How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus–Associated Cryptococcal Meningitis to High-Income Settings?
por: Harrison, Thomas S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lhbtbj4rfoc2rht8t13qp2rcpd